Long-term renal allograft survival: Prognostic implication of the timing of acute rejection episodes

Transplantation

Volumn 63, Issue 9, 1997, Pages 1268-1272

  Leggat Jr , John E ^a   Ojo, Akinlolu O ^a,b   Leichtman, Alan B ^a   Port, Friedrich K ^a   Wolfe, Robert A ^a   Turenne, Mark N ^a   Held, Philip J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY DONOR; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECIPIENT; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; EVALUATION STUDIES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TIME FACTORS;

EID: 0030972876     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199705150-00013     Document Type: Article

References (25)

1. Renal Data System. USRDS 1996 annual data report. Bethesda, MD: National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, April 1996.
2. Gjertson DW, Cecka JM, Terasaki PI. The relative effects of FK506 and cyclosporin on short- and long-term kidney graft survival. Transplantation 1995; 60: 1384.
3. Ferguson R. Acute rejection episodes: best predictor of long-term primary cadaveric renal transplant survival. Clin Transplant 1994; 8: 328.
4. 1/2). Transplantation 1994; 57: 857.
5. Sumrani N, Delaney V, Hong JH, Daskalkis P, Friedman EA, Sommer BG. Renal allograft outcome in the cyclosporin era: comparison between intermediate-term failure and long-term survival. ASAIO J 1991; 37: 623.
6. Cole E, Naimark D, Aprile M, et al. An analysis of predictors of long-term cadaveric renal allograft survival. Clin Transplant 1995; 9: 282.
7. Basadonna GP, Matas AJ, Gillingham KJ, et al. Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation 1993; 55: 993.
8. Sumrani N, Cacciarelli TV, Georgi B, et al. Contribution of acute rejection to renal allograft loss from chronic rejection. Transplant Proc 1993; 25: 2259.
9. Didlake RH, Dreyfus RH, Van Buren CT, Kahan BD. Patient noncompliance: a major cause of late graft failure in cyclosporin-treated renal transplants. Transplant Proc 1988; 20 (suppl 3): 63.
10. Ojo AO, Port FK, Held PJ, et al. Inferior outcome of two-haplotype matched renal transplants in blacks: role of early rejection. Kidney Int 1995; 48: 1592.
11. Cecka JM, Terasaki, PI. The UNOS scientific renal transplant registry. In: Terasaki PI, Cecka JM, eds. Clinical transplants 1993. Los Angeles: UCLA Tissue Typing Laboratory, 1993: 1.
12. Cox DR. Regression models and life tables [with discussion]. J R Stat Soc 1972; 34: 197.
13. SAS Institute Inc. SAS/STAT software: changes and enhancements through release 6.11. Cary, NC: SAS Institute, Inc., 1996: 807.
14. Koyama M, Cecka JM, Terasaki PI. Kidney transplantation in black recipients: HLA matching and other factors affecting long-term graft survival. Transplantation 1994; 57: 1064.
15. First MR, Schroeder TJ, Monaco AP, Simpson MA, Curtis JJ, Armenti VT. Cyclosporine bioavailability: dosing implications and impact on clinical outcomes in select transplantation sub-populations. Clin Transplant 1996; 10: 55.
16. Hoppu K, Koskimies O, Holmberg C, Hirvisalo EL. Evidence for pre-hepatic metabolism of oral cyclosporine in children. Br J Clin Pharmacol 1991; 32: 477.
17. De Geest S, Borgermans L, Gemoets H, et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation 1995; 59: 340.
18. Starzl TE. Cell migration and chimerism: a unifying concept in transplantation, with particular reference to HLA matching and tolerance induction. Transplant Proc 1993; 25: 8.
19. van Twuyver E, de Hoop J, ten Berge RJM, et al. Comparison of T cell responses in patients with a long-term surviving renal allograft versus a long-term surviving liver allograft: it's a different world. Transplantation 1996; 61: 1392.
20. Kasiske BL, Heim-Duthoy K, Ma JZ. Elective cyclosporine withdrawal after renal transplantation: a meta-analysis. JAMA 1993; 269: 395.
21. Mazariegos GV, Ramos R, Shapiro R, Zeevi A, Fung JJ, Starzl TE. Weaning of immunosuppression in long-term recipients of living related transplant: a preliminary study. Transplant Proc 1995; 27: 207.
22. Chertow GM, Brenner BM, Mackenzie HS, Milford EL. Non-immunologic predictors of chronic renal: data from the United Network of Organ Sharing. Kidney Int 1995; 48 (suppl 52): 48.
23. Peeters J, Roels L, Vanreterghem Y. Chronic renal allograft failure: clinical overview. Kidney Int 1995; 48 (suppl 52): 97.
24. Brenner BM, Cohen RA, Milford EL. In renal transplantation, one size may not fit all. J Am Soc Nephrol 1992; 3: 162.
25. Troppmann C, Gillingham KJ, Gruessner RWG, et al. Delayed graft function in the absence of rejection has no long-term impact: a study of cadaver kidney recipients with good graft function at 1 year after transplantation. Transplantation 1996; 61: 1331.